OPEN END-TURBO-OPTIONSSCHEIN - RESMED | Market Closed - Börse Stuttgart 20:41:51 31/05/2024 BST | ||
| 0.69 EUR | -33.01% |
|
| Current month | -53.38% | ||
| 1 month | -53.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 0.69 | -33.01% |
| 30/05/24 | 1.03 | +43.06% |
| 29/05/24 | 0.72 | -14.29% |
| 28/05/24 | 0.84 | -40.00% |
| 27/05/24 | 1.4 | +2.94% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 08:41 pm
More quotesStatic data
| Product type | Knock-Out sin Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | HSBC |
| WKN | HS697L |
| ISIN | DE000HS697L2 |
| Date issued | 26/04/2024 |
| Strike | 200.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.49 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.14 € |
|---|---|
| Lowest since issue | 0.61 € |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
206.3
USD
Average target price
216.6
USD
Spread / Average Target
+5.00%
- Stock Market
- Certificates
- Certificat
